We found that CDKN2B-AS1 shRNA notably decreased CDKN2B-AS1 expression in tumor tissues, accompanied by an increase of miR-378b and a decrease of CAPRIN2 (Figure 7a–e). Here, CAPRIN2 is linked to neoplasm.